Lim Shen-Yang, Tan Ai Huey, Foo Jia Nee, Tan Yi Jayne, Chew Elaine Gy, Annuar Azlina Ahmad, Closas Alfand Marl Dy, Pajo Azalea, Lim Jia Lun, Tay Yi Wen, Nadhirah Anis, Hor Jia Wei, Toh Tzi Shin, Lit Lei Cheng, Zulkefli Jannah, Ngim Su Juen, Lim Weng Khong, Morris Huw R, Tan Eng-King, Ng Adeline Sl
Division of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
The Mah Pooi Soo & Tan Chin Nam Centre for Parkinson's & Related Disorders, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
J Mov Disord. 2024 Apr;17(2):213-217. doi: 10.14802/jmd.24009. Epub 2024 Jan 31.
Lysosomal dysfunction plays an important role in neurodegenerative diseases, including Parkinson's disease (PD) and possibly Parkinson-plus syndromes such as progressive supranuclear palsy (PSP). This role is exemplified by the involvement of variants in the GBA1 gene, which results in a deficiency of the lysosomal enzyme glucocerebrosidase and is the most frequently identified genetic factor underlying PD worldwide. Pathogenic variants in the SMPD1 gene are a recessive cause of Niemann-Pick disease types A and B. Here, we provide the first report on an association between a loss-of-function variant in the SMPD1 gene present in a heterozygous state (p.Pro332Arg/p.P332R, which is known to result in reduced lysosomal acid sphingomyelinase activity), with PSP-Richardson syndrome in three unrelated patients of Chinese ancestry.
溶酶体功能障碍在神经退行性疾病中起重要作用,包括帕金森病(PD)以及可能的帕金森叠加综合征,如进行性核上性麻痹(PSP)。GBA1基因变异的参与就例证了这一作用,该变异导致溶酶体酶葡萄糖脑苷脂酶缺乏,是全球范围内PD最常被鉴定出的遗传因素。SMPD1基因的致病性变异是A型和B型尼曼-匹克病的隐性病因。在此,我们首次报告了在三名无亲缘关系的华裔患者中,杂合状态存在的SMPD1基因功能丧失变异(p.Pro332Arg/p.P332R,已知会导致溶酶体酸性鞘磷脂酶活性降低)与PSP-理查森综合征之间的关联。